Your A-Z of episodes

Did you know there’s even more we can do to promote your episode? Find out more…

  • Episode 205

    Meet the healthcare futurist

    Imran Kausar

    / DeepHealth Consulting

    Imran Kausar, Founder of DeepHealth Consulting, joins the podcast to discuss gene therapies, their pricing, and the value they bring to patients.

  • Episode 204

    The dynamic duo driving global growth

    Myonex

    / James Lovett & Mike Cohen

    James Lovett & Mike Cohen from Myonex join the podcast to share insights on driving success in clinical trials and fueling sustainable organic growth.

  • Episode 203

    Biopharma Insights: Live from J.P. Morgan

    Dean McAlister

    / Inizio Biotech

    Dean McAlister, EVP at Inizio Biotech, joins the podcast live from J.P. Morgan 2025 to share insights on the life sciences sector outlook.

  • Episode 202

    The CEO making a global impact

    Peter DeYoung

    / Piramal Global Pharma

    Discover what makes Piramal Global Pharma a standout in the CDMO space as CEO Peter DeYoung reveals their “secret sauce” to success.

  • Episode 201

    2024 reflections and 2025 outlook in pharma services

    Ian Tzeng

    / L.E.K.

    Ian Tzeng, Managing Director & Partner at L.E.K., joins the podcast to discuss the outlook for 2025 in the pharma services sector.

  • Episode 200

    From questions to answers: Celebrating 200 episodes

    JoyL Silva

    / Pfizer

    In this special episode, Raman takes the hot seat and is interviewed by JoyL Silva to commemorate 200 episodes of Molecule to Market.

  • Episode 199

    Charles River’s lifelong CDMO leader

    Kerstin Dolph

    / Charles River Laboratories

    Kerstin Dolph, SVP of Manufacturing at Charles River Labs, shares insights from her 23-year journey and diverse roles at the business.

  • Episode 198

    The pharma ingredients disruptor

    Jack Stine

    / Savendor

    Jack Stine, CEO at Savendor, shares his journey and motivations for launching his own business in the pharma outsourcing industry.

  • Episode 197

    Baking success to IQVIA exit

    Tessa Pugh

    / PharmaReview

    Tessa Pugh, ex-CEO at PharmaReview, shares her journey from co-founder to CEO, driving growth and leading a PE-backed exit to IQVIA.

  • Episode 196

    The biotech-MedTech CEO tackling obesity

    Camila Easter

    / Oxford Medical Products (OMP)

    Camila Easter, CEO at Oxford Medical Products, shares her journey from the veterinary field to making waves in the GLP-1 space.

  • Load more